Belite Bio (BLTE) Prepaid Assets (2021 - 2025)
Belite Bio's (BLTE) quarterly Prepaid Assets came in at $486000.0 in Q4 2025, up 17.39% year-on-year from $414000.0 in Q4 2024, and down 69.49% quarter-over-quarter from $1.6 million in Q3 2025.
Belite Bio (BLTE) Prepaid Assets (2021 - 2025) Analysis & Trends
Belite Bio's Prepaid Assets history runs 5 years deep, the most recent figure standing at $486000.0 for Q4 2025.
- On a quarterly basis, Prepaid Assets rose 17.39% year-over-year to $486000.0 in Q4 2025; TTM through Dec 2025 was $486000.0, a 17.39% increase from a year earlier, with the FY2025 full-year figure at $486000.0, up 17.39% from the prior year.
- Prepaid Assets eased to $486000.0 in Q4 2025 per BLTE's latest filing, from $1.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.6 million in Q3 2025 and bottomed at $50000.0 in Q4 2021.
- The 5-year median for Prepaid Assets is $601000.0 (2022), against an average of $701000.0.
- Across the five-year window, Prepaid Assets surged 1332.0% in 2022 and tumbled 56.28% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $50000.0 in 2021, then jumped by 1332.0% to $716000.0 in 2022, then jumped by 32.26% to $947000.0 in 2023, then tumbled by 56.28% to $414000.0 in 2024, then advanced by 17.39% to $486000.0 in 2025.
- Per Business Quant, the three latest BLTE Prepaid Assets figures stand at $486000.0 (Q4 2025), $1.6 million (Q3 2025), and $414000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 486,000.00 |
| Sep 30, 2025 | 1.59 Mn |
| Dec 31, 2024 | 414,000.00 |
| Dec 31, 2023 | 947,000.00 |
| Dec 31, 2022 | 716,000.00 |
| Dec 31, 2021 | 50,000.00 |